Cargando…
Subgroup identification for treatment selection in biomarker adaptive design
BACKGROUND: Advances in molecular technology have shifted new drug development toward targeted therapy for treatments expected to benefit subpopulations of patients. Adaptive signature design (ASD) has been proposed to identify the most suitable target patient subgroup to enhance efficacy of treatme...
Autores principales: | Lu, Tzu-Pin, Chen, James J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673750/ https://www.ncbi.nlm.nih.gov/pubmed/26646831 http://dx.doi.org/10.1186/s12874-015-0098-7 |
Ejemplares similares
-
A Composite Model for Subgroup Identification and Prediction via Bicluster Analysis
por: Chen, Hung-Chia, et al.
Publicado: (2014) -
Optimizing subgroup selection in two‐stage adaptive enrichment and umbrella designs
por: Ballarini, Nicolás M., et al.
Publicado: (2021) -
IBIS: identify biomarker-based subgroups with a Bayesian enrichment design for targeted combination therapy
por: Chen, Xin, et al.
Publicado: (2023) -
Selecting Optimal Subgroups for Treatment Using Many Covariates
por: VanderWeele, Tyler J., et al.
Publicado: (2019) -
A Bayesian adaptive design for biomarker trials with linked treatments
por: Wason, James M S, et al.
Publicado: (2015)